Timea |
15 |
30 |
45 |
60 |
75 |
90 |
105 |
120 |
|
b2b |
r2c |
b2 |
r2 |
b2 |
r2 |
b2 |
r2 |
b2 |
r2 |
b2 |
r2 |
b2 |
r2 |
b2 |
r2 |
Silicad |
6.31 |
0.95 |
10.2 |
0.94 |
16.7 |
0.95 |
26.9 |
0.93 |
38.4 |
0.95 |
43.3 |
0.96 |
41.1 |
0.97 |
35.7 |
0.97 |
HSe |
1.75 |
0.59 |
3.92 |
0.99 |
6.89 |
0.99 |
12.1 |
1.00 |
17.2 |
0.98 |
22.1 |
0.99 |
23.5 |
0.99 |
22.6 |
0.99 |
Ratiof |
3.60 |
|
2.61 |
|
2.43 |
|
2.23 |
|
2.23 |
|
1.96 |
|
1.75 |
|
1.58 |
|
aTime after administration (min). bβ2 (×10−8) is the slope of the
regression line for β1 in Table 2 and particle size (the number average
particle diameter). cSquare of the correlation coefficient of the
regression line for β1 in Table 2 and particle size. dGroup of four silica samples. eGroup of heat-treated four silica samples (HS). fβ2 of silic /β2 of HS. |